Tag: 2020

Andrew Moon, MD, MPH, a fellow in the division of gastroenterology and hepatology, is lead author of a study finding one in five patients with NAFLD have prior prescription opioid use. Sidney Barritt, MD, MSCR, associate professor, is a co-author. Target RWE, an innovative health evidence solutions company generating real-world...

David Wohl, MD, professor of medicine in the division of infectious diseases offered advice on what to do after exposure to the coronavirus. “If you’ve been exposed to a known case of COVID-19, your job is to stay out of circulation, be away from people and then after some time...

In a new UNC Health Media Briefing on COVID-19, David Wohl, MD, answers questions on topics that include: • What we know about President Donald Trump’s battle with COVID-19. • How UNC Health medical specialists are using Remdesivir and Dexamethasone as well as experimental treatments to help COVID-19 patients. •...

WUNC Producer Charlie Shelton-Ormond talked with Cindy Gay, MD, MPH, associate professor of medicine in the division of infectious diseases, the primary investigator of a Phase 3 clinical trial for a COVID vaccine taking place at UNC-Chapel Hill. Learn more from the UNC Health and UNC School of Medicine Newsroom.

The third episode of a new series produced by Medscape Video features the work of three members of the UNC Behavior and Technology Lab in the division of infectious diseases. The series, titled “Confronting the HIV Epidemic,” includes interviews with BATLab Director Lisa Hightow-Weidman, MD, MPH; BATLAB Global Division Director Kate Muessig, PhD; and Lina Rosengren-Hovee, MD, MPH, MS, the...

At the onset of the global pandemic, infectious disease colleagues at Carolina and across the U.S. pivoted quickly and formed the COVID Prevention Network (CoVPN). The network coordinates multiple studies, including the current phase 3 clinical trial for Moderna’s mRNA-1273 COVID-19 vaccine. The overall goal of the national study is to...

David Weber, MD, MPH, professor of medicine in the division of infectious diseases, professor of pediatrics, and professor of epidemiology with the UNC Gillings School of Global Public Health, was featured in a Blue Ridge Public Radio story that recognized how Mission Health decides to test surgery patients for COVID-19. ...

Emily Sickbert-Bennett, PhD, MS, associate professor of infectious diseases, explained to USA Today that even if a farm doesn’t require it, people should practice social distancing by staying six feet apart from others, and always wear a face mask while enjoying outdoor activities such as apple picking. “Wearing your mask...

Through a third round of funding from the National Institute on Aging (NIA), UNC’s Medical Students Training in Aging Research – MSTAR – program will continue as a National Training Center from 2020 through 2025.

John Buse, MD, PhD, will lead the UNC-Chapel Hill site for a collaborative NIH research effort to discover new forms of diabetes, understand their differences, and identify their causes. UNC-Chapel Hill is participating in a nationwide study funded by the National Institutes of Health that will seek to discover the...

In a WRAL interview, Melissa Sickbert-Bennett, PhD, MS, associate professor of medicine in the division of infectious diseases, commented on superspreader events and precautions that are needed after a recent White House ceremony was found to be linked to eight coronavirus cases. “The mask is our best protection to both...

Researchers at Oxford and UNC-Chapel Hill, led by Andrew Moon, MD, MPH, and Sidney Barritt, MD, found increased mortality rates among COVID-19 patients with advanced cirrhosis and alcohol-related liver disease. The study, published in the Journal of Hepatology, found that mortality from COVID-19 was particularly high among patients with more advanced...